![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 08, 2016 9:53:54 AM
Alferon-N and Alferon LDO experimental are very interesting drugs. LDO has huge potential. There was an ape study a number of years ago where LDO beat the heck out of tamiflu for flu prevention. Here is a reference pr.
http://hemispherx.net/content/investor/default.asp?goto=799
re: you business concern. They are a tiny biotech trying to do great things. Creating drugs, the facilities to produce them and getting them approved is very complicated business. Biotech sector is a risky business - high risk = high reward. Often, things do not go smoothly.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM